BridgeBio Pharma, Inc. (BBIO) ROI
- 2021-03-31: ROI 190.27%.
- 2020-12-31: ROI -333.03%.
Complete source-backed roi history.
- Available history
- 2020-12-31 to 2021-03-31
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2021-03-31 | 190.27% |
| 2020-12-31 | -333.03% |
Annual ROI
| Date | ROI |
|---|---|
| 2020-12-31 | -333.03% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |